[Primary prevention of gastroduodenal ulcer: what is the evidence?]. / Prévention primaire de l'ulcère gastro-duodénal: quelles évidences?
Rev Med Suisse
; 2(83): 2337-8, 2340, 2342-3, 2006 Oct 18.
Article
em Fr
| MEDLINE
| ID: mdl-17112084
ABSTRACT
Primary prevention of gastroduodenal ulcer and its major complication, gastrointestinal bleeding, has been studied mainly in the intensive care environment. Proton pump inhibitors (PPIs), H2-receptor antagonists and sucralfate have proved effective. By extension, PPIs are inappropriately prescribed in a variety of clinical situations. In contrast, they are probably underused in patients chronically treated by nonsteroidal anti-inflammatory drugs. This article reviews the situations in which an increased ulcer risk justifies primary prevention. Validated prophylactic options are also addressed.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Úlcera Péptica
/
Prevenção Primária
Idioma:
Fr
Ano de publicação:
2006
Tipo de documento:
Article